Eileen Maziarz

Journal Article J Clin Virol · February 2025 BACKGROUND: EBV DNAemia surveillance, with reduction of immunosuppression at certain viral load (VL) thresholds, is a common practice for mitigating progression from EBV DNAemia to post-transplant lymphoproliferative disorder (PTLD) in lung transplant reci ... Full text Link to item Cite

Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept.

Journal Article Transpl Infect Dis · 2025 BACKGROUND: Belatacept is a costimulatory blocker that can be used to prevent and treat rejection in lung transplant recipients (LuTRs). The epidemiology of infections in belatacept-treated LuTRs has not been systematically evaluated. METHODS: We performed ... Full text Link to item Cite

Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With Pneumonia.

Journal Article Open Forum Infect Dis · August 2024 BACKGROUND: Plasma microbial cell-free DNA (mcfDNA) sequencing can establish the etiology of multiple infectious syndromes by identifying microbial DNA in plasma. However, data are needed to define the clinical scenarios where this tool offers the highest ... Full text Link to item Cite

View All Publications

Education, Training & Certifications

University of Nebraska, College of Medicine · 2007 M.D.

Eileen Maziarz

Current Appointments & Affiliations

Recent Publications

Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients.

Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept.

Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With Pneumonia.

Recent Grants

VTEU 14-0053 Task C Option 2 Protocol Implementation

Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)

VTEU 14-0053 Task C Option 4 Protocol Implementation

Education, Training & Certifications